• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在进行肾盂输尿管切除术之前进行诊断性输尿管镜检查,尽管采取了技术预防措施以避免肿瘤溢出,但与膀胱癌复发的高风险相关。

Diagnostic ureteroscopy prior to nephroureterectomy for urothelial carcinoma is associated with a high risk of bladder recurrence despite technical precautions to avoid tumor spillage.

机构信息

Department of Urology and Renal Transplantation, La Conception University Hospital, APHM, Aix-Marseille University, 13005, Marseille, France.

Department of Urology, Nord University Hospital, APHM, Aix-Marseille University, Marseille, France.

出版信息

World J Urol. 2020 Jan;38(1):159-165. doi: 10.1007/s00345-019-02768-w. Epub 2019 Apr 16.

DOI:10.1007/s00345-019-02768-w
PMID:30993427
Abstract

PURPOSE

There have recent reports in the literature of increased rates of bladder recurrence (BR) after radical nephroureterectomy (RNU) when diagnostic flexible ureteroscopy (DFU) was performed before RNU. The technical heterogeneity of DFU was a major bias in these studies. Our purpose was to evaluate the impact of a standardized DFU technique before RNU on the risk of BR.

METHODS

A retrospective monocenter study including patients who underwent RNU for upper tract urothelial carcinoma (UTUC) between 2005 and 2017. 171 patients were identified. 78 patients were excluded owing to a history of bladder cancer before RNU or neo-adjuvant/adjuvant chemotherapy. 93 included patients were stratified according to pre-RNU ureteroscopy (DFU + 70 patients) or no pre-RNU ureteroscopy (DFU-23 patients). The standardized DFU technique consisted of systematic ureteral sheath (ch9-10), flexible ureteroscopy, biopsy, and drainage with a mono-J/bladder catheter to avoid contact of contaminated urine of the upper tract with the bladder.

RESULTS

Epidemiological, initial staging, and postoperative tumoral characteristics were similar in both groups. Mean follow-up was 35 months [2-166], 47(50%) BR occurred with 41(87%) in the DFU + group, and pre-RNU-DFU was an independent predictive factor of BR (OR = 4[1.4-11.9], P = 0.01) (Cox regression model). The characteristics of BR were similar in both groups, although BR occurred earlier in DFU + (427 days vs. 226 days (P = 0.07)).

CONCLUSION

Bladder recurrence after diagnostic ureteroscopy + nephroureterectomy was high despite technical precautions to avoid contact of bladder mucosa with contaminated urine from the upper urinary tract. Post-DFU endovesical instillation should be investigated.

摘要

目的

文献中有报道称,在根治性肾输尿管切除术(RNU)前行诊断性软性输尿管镜检查(DFU)后,膀胱癌复发(BR)的发生率增加。这些研究中,DFU 的技术异质性是一个主要的偏倚。我们的目的是评估 RNU 前行标准化 DFU 技术对 BR 风险的影响。

方法

这是一项回顾性单中心研究,纳入 2005 年至 2017 年间接受 RNU 治疗上尿路尿路上皮癌(UTUC)的患者。共确定了 171 例患者。78 例患者因 RNU 前膀胱癌病史或新辅助/辅助化疗而被排除。根据 RNU 前行输尿管镜检查(DFU+70 例)或未行 RNU 前行输尿管镜检查(DFU-23 例),将 93 例纳入患者进行分层。标准化 DFU 技术包括系统输尿管鞘(ch9-10)、软性输尿管镜检查、活检和引流,使用单 J/膀胱导管以避免上尿路污染尿液与膀胱接触。

结果

两组的流行病学、初始分期和术后肿瘤特征相似。平均随访时间为 35 个月[2-166],DFU+组有 47(50%)例发生 BR,其中 41(87%)例发生在 RNU 前行 DFU 组,RNU 前行 DFU 是 BR 的独立预测因素(OR=4[1.4-11.9],P=0.01)(Cox 回归模型)。两组的 BR 特征相似,尽管 DFU+组的 BR 更早发生(427 天比 226 天,P=0.07)。

结论

尽管采取了技术预防措施以避免膀胱黏膜与上尿路污染尿液接触,但在诊断性输尿管镜检查+肾输尿管切除术(RNU)后,膀胱癌复发率仍然很高。应研究 RNU 后行膀胱内灌洗。

相似文献

1
Diagnostic ureteroscopy prior to nephroureterectomy for urothelial carcinoma is associated with a high risk of bladder recurrence despite technical precautions to avoid tumor spillage.在进行肾盂输尿管切除术之前进行诊断性输尿管镜检查,尽管采取了技术预防措施以避免肿瘤溢出,但与膀胱癌复发的高风险相关。
World J Urol. 2020 Jan;38(1):159-165. doi: 10.1007/s00345-019-02768-w. Epub 2019 Apr 16.
2
The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-Analysis.上尿路尿路上皮癌诊断方式对根治性肾输尿管切除术术后膀胱内复发的影响:单中心系列研究和更新的荟萃分析。
J Urol. 2021 Sep;206(3):558-567. doi: 10.1097/JU.0000000000001834. Epub 2021 Apr 28.
3
Bladder Recurrence Following Diagnostic Ureteroscopy in Patients Undergoing Nephroureterectomy for Upper Tract Urothelial Cancer: Is Ureteral Access Sheath Protective?接受上尿路尿路上皮癌根治性肾输尿管切除术患者诊断性输尿管镜检查后的膀胱复发:输尿管接入鞘有保护作用吗?
Urology. 2022 Feb;160:142-146. doi: 10.1016/j.urology.2021.11.026. Epub 2021 Dec 18.
4
The Effect of Diagnostic Ureterorenoscopy on Intravesical Recurrence in Patients Undergoing Nephroureterectomy for Primary Upper Tract Urinary Carcinoma.诊断性输尿管镜检查对上尿路尿路上皮癌患者行肾输尿管切除术后膀胱内复发的影响。
Urol Int. 2021;105(3-4):291-297. doi: 10.1159/000511650. Epub 2020 Dec 2.
5
Risk Factors for Intravesical Recurrence after Minimally Invasive Nephroureterectomy for Upper Tract Urothelial Cancer (ROBUUST Collaboration).微创肾输尿管切除术治疗上尿路尿路上皮癌后膀胱内复发的危险因素(ROBUUST 协作组)。
J Urol. 2021 Sep;206(3):568-576. doi: 10.1097/JU.0000000000001786. Epub 2021 Apr 21.
6
Impact of diagnostic ureteroscopy before radical nephroureterectomy on intravesical recurrence in patients with upper tract urothelial cancer.诊断性输尿管镜检查在前位根治性肾输尿管切除术对治疗上尿路尿路上皮癌患者膀胱内复发的影响。
Investig Clin Urol. 2020 Mar;61(2):158-165. doi: 10.4111/icu.2020.61.2.158. Epub 2020 Feb 4.
7
Ten-year survival outcomes after radical nephroureterectomy with a risk-stratified approach using prior diagnostic ureteroscopy: a single-institution observational retrospective cohort study.基于术前诊断性输尿管镜检查的风险分层方法行根治性肾输尿管切除术的 10 年生存结果:单机构观察性回顾性队列研究。
BJU Int. 2022 Jun;129(6):744-751. doi: 10.1111/bju.15627. Epub 2021 Nov 24.
8
Diagnostic Ureteroscopy Prior to Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma Increased the Risk of Intravesical Recurrence.上尿路尿路上皮癌根治性肾输尿管切除术前行诊断性输尿管镜检查增加了膀胱内复发的风险。
Urol Int. 2018;100(1):92-99. doi: 10.1159/000484417. Epub 2017 Dec 8.
9
Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.保留肾单位手术与根治性肾输尿管切除术治疗上尿路上皮癌的肿瘤学结局:EAU 非肌肉浸润性膀胱癌指南小组的系统评价。
Eur Urol. 2016 Dec;70(6):1052-1068. doi: 10.1016/j.eururo.2016.07.014. Epub 2016 Jul 28.
10
Diagnostic Ureterorenoscopy Is Associated with Increased Intravesical Recurrence following Radical Nephroureterectomy in Upper Tract Urothelial Carcinoma.诊断性输尿管肾镜检查与上尿路尿路上皮癌根治性肾输尿管切除术后膀胱内复发增加有关。
PLoS One. 2015 Nov 10;10(11):e0139976. doi: 10.1371/journal.pone.0139976. eCollection 2015.

引用本文的文献

1
Intravesical instillation of chemotherapy before surgery for upper tract urothelial cancer.上尿路尿路上皮癌手术前膀胱内化疗灌注
Bladder Cancer. 2025 May 6;11(2):23523735251332755. doi: 10.1177/23523735251332755. eCollection 2025 Apr-Jun.
2
Strategies to reduce bladder tumor recurrences following surgery for upper tract urothelial carcinoma.降低上尿路尿路上皮癌手术后膀胱肿瘤复发的策略。
Bladder (San Franc). 2024 Jul 31;11(1):e21200001. doi: 10.14440/bladder.2024.0007. eCollection 2024.
3
Diagnosing upper tract urothelial carcinoma: A review of the role of diagnostic ureteroscopy and novel developments over last two decades.

本文引用的文献

1
Discordance between Ureteroscopic Biopsy and Final Pathology for Upper Tract Urothelial Carcinoma.输尿管镜活检与上尿路尿路上皮癌最终病理的不相符。
J Urol. 2018 Jun;199(6):1440-1445. doi: 10.1016/j.juro.2018.02.002. Epub 2018 Feb 7.
2
Impact of ureteroscopy before radical nephroureterectomy for upper tract urothelial carcinomas on oncological outcomes: a meta-analysis.根治性肾输尿管切除术治疗上尿路尿路上皮癌前输尿管镜检查对肿瘤学结局的影响:一项荟萃分析
BJU Int. 2018 Feb;121(2):184-193. doi: 10.1111/bju.14053. Epub 2017 Nov 1.
3
Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis.
诊断上尿路尿路上皮癌:过去二十年诊断性输尿管镜检查作用及新进展综述
Asian J Urol. 2024 Apr;11(2):242-252. doi: 10.1016/j.ajur.2022.08.003. Epub 2022 Sep 23.
4
Predictive factors of bladder tumor recurrence after radical treatment of upper urinary tract cancer.根治性治疗上尿路尿路上皮癌后膀胱癌复发的预测因素。
Tunis Med. 2023 Mar 5;101(3):356-361.
5
Upper Tract Urothelial Carcinoma (UTUC) Diagnosis and Risk Stratification: A Comprehensive Review.上尿路尿路上皮癌(UTUC)的诊断与风险分层:综述
Cancers (Basel). 2023 Oct 14;15(20):4987. doi: 10.3390/cancers15204987.
6
Biopsy with Ureterorenoscopy Before Radical Nephroureterectomy is Associated with Increased Intravesical Recurrence in Urothelial Cancer Located in the Kidney.在根治性肾输尿管切除术前行输尿管肾镜活检与肾脏尿路上皮癌膀胱内复发增加相关。
Turk J Urol. 2022 Nov;48(6):431-439. doi: 10.5152/tud.2022.22143.
7
Whether diagnostic ureteroscopic biopsy and ureteroscopy without biopsy have different impacts on intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomy?诊断性输尿管镜活检与未进行活检的输尿管镜检查对根治性肾输尿管切除术后上尿路尿路上皮癌膀胱内复发是否有不同影响?
World J Urol. 2022 Aug;40(8):2135-2137. doi: 10.1007/s00345-022-04064-6. Epub 2022 May 28.
8
Comment on "Durability of response to primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel: OLYMPUS trial final report".关于“使用含丝裂霉素的反向热凝胶UGN - 101对低级上尿路尿路上皮癌进行初次化学消融治疗的反应持久性:OLYMPUS试验最终报告”的评论
World J Urol. 2022 May;40(5):1251-1252. doi: 10.1007/s00345-022-03968-7. Epub 2022 Feb 22.
9
Re: How to Manage Patients with Suspected Upper Tract Urothelial Carcinoma in the Pandemic of COVID-19?关于:在2019年冠状病毒病大流行期间如何管理疑似上尿路尿路上皮癌患者?
Eur Urol. 2022 May;81(5):543. doi: 10.1016/j.eururo.2022.01.017. Epub 2022 Jan 19.
10
Predictive Value of Preoperative Positive Urine Cytology for Development of Bladder Cancer After Nephroureterectomy in Patients With Upper Urinary Tract Urothelial Carcinoma: A Prognostic Nomogram Based on a Retrospective Multicenter Cohort Study and Systematic Meta-Analysis.上尿路尿路上皮癌患者肾输尿管切除术后术前尿细胞学阳性对膀胱癌发生的预测价值:基于回顾性多中心队列研究和系统Meta分析的预后列线图
Front Oncol. 2021 Oct 1;11:731318. doi: 10.3389/fonc.2021.731318. eCollection 2021.
诊断性输尿管镜检查对上尿路尿路上皮癌根治性肾输尿管切除术患者膀胱内复发的影响:一项系统评价和荟萃分析。
BJU Int. 2017 Sep;120(3):313-319. doi: 10.1111/bju.13935. Epub 2017 Jul 19.
4
Cancer Statistics, 2017.《2017 年癌症统计》
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.
5
Risk of Intravesical Recurrence After Ureteroscopic Biopsy for Upper Tract Urothelial Carcinoma: Does the Location Matter?上尿路尿路上皮癌输尿管镜活检后膀胱内复发的风险:位置重要吗?
J Endourol. 2017 Mar;31(3):259-265. doi: 10.1089/end.2016.0611. Epub 2016 Nov 29.
6
Diagnostic Ureteroscopy for Upper Tract Urothelial Carcinoma is Independently Associated with Intravesical Recurrence after Radical Nephroureterectomy.诊断性输尿管镜检查用于上尿路尿路上皮癌与根治性肾输尿管切除术后膀胱内复发独立相关。
Int Braz J Urol. 2016 Nov-Dec;42(6):1129-1135. doi: 10.1590/S1677-5538.IBJU.2015.0366.
7
Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.保留肾单位手术与根治性肾输尿管切除术治疗上尿路上皮癌的肿瘤学结局:EAU 非肌肉浸润性膀胱癌指南小组的系统评价。
Eur Urol. 2016 Dec;70(6):1052-1068. doi: 10.1016/j.eururo.2016.07.014. Epub 2016 Jul 28.
8
Impact of Ureteroscopy Before Nephroureterectomy for Upper Tract Urothelial Carcinoma on Oncologic Outcomes.上尿路尿路上皮癌根治性肾输尿管切除术前行输尿管镜检查对肿瘤学结局的影响
Urology. 2016 Aug;94:148-53. doi: 10.1016/j.urology.2016.05.039. Epub 2016 May 26.
9
Diagnostic Ureterorenoscopy Is Associated with Increased Intravesical Recurrence following Radical Nephroureterectomy in Upper Tract Urothelial Carcinoma.诊断性输尿管肾镜检查与上尿路尿路上皮癌根治性肾输尿管切除术后膀胱内复发增加有关。
PLoS One. 2015 Nov 10;10(11):e0139976. doi: 10.1371/journal.pone.0139976. eCollection 2015.
10
Correlation Between the Timing of Diagnostic Ureteroscopy and Intravesical Recurrence in Upper Tract Urothelial Cancer.诊断性输尿管镜检查时机与上尿路尿路上皮癌膀胱内复发的相关性
Clin Genitourin Cancer. 2016 Feb;14(1):e37-41. doi: 10.1016/j.clgc.2015.07.008. Epub 2015 Aug 6.